How Monoclonal Antibodies produce lasting anti... - CLL Support

CLL Support

22,367 members38,474 posts

How Monoclonal Antibodies produce lasting antitumour effects

AussieNeil profile image
AussieNeilAdministrator
0 Replies

This Hematology times article examines research into how CD 20 Monoclonal Antibodies such as Mabthera®/Rituximab/Rituxan (the R in FCR) and obinutuzumab/GAZYVA®, trigger macrophages to engulf and destroy our B-CLL cells when we are treated with immunochemotherapy. What's exciting about this (mouse model research), is the researchers have found that CD20 antibodies actually deliver a two stage response; firstly by labelling the cancerous B-cells for destruction and secondly, by triggering the development of memory T cells that will continue to aid the destruction of new B-cell clones (as long as they have the CD20 marker), long after we are treated. (Given CLL always comes back, this is really exciting news!) They found that they could enhance this memory cell production in mice, which resulted in longer lasting remissions. Could this be the mechanism by which some FCR patients appear to be cured?

hematologytimes.com/p_artic...

Neil

Photo: Lichens growing on a twig.

Written by
AussieNeil profile image
AussieNeil
Administrator
To view profiles and participate in discussions please or .
Read more about...

You may also like...

Preventive monoclonal antibodies

write to the FDA about approving use of the monoclonal antibodies to help prevent COVID among the...

Monoclonal antibody infusion

days ago, he received the monoclonal antibody infusion on day 4. He had received a letter from our...

Monoclonal antibodies vs. Paxlovid

rebound effect. Did those of you who received monoclonal antibody infusions at a hospital or clinic...

Calling UK CLLers - Is government about to abandon support for protective monoclonal antibodies?

https://www.sciencemag.org/news/2021/01/monoclonal-antibodies-protect-against-covid-19-second-study...

Access to Monoclonal Antibody Treatment in Mexico

I have CLL and in W&W. Age 65, otherwise healthy. No antibodies after first 2 Pfizers, positive for...